Financial News Commentary on CVS - CVS Caremark Corporation

Interested in CVS? See What the Pundits Said on WSJ Marketbeat

The latest news on WSJ Marketbeat in regards to CVS came through on RazorWire recently.

As we analyze the results from RazorWire, one thing we do is rank each stock in terms of amount of news coverage. Recently, CVS has been less covered in the news compared to the rest of our universe of stocks. The Motley Fool CAPS data suggests that investors believe CVS Caremark Corporation will beat the market in the foreseeable future. We consider CVS as Undervalued at the current price of $35.03. According to our methodology, this stock has appreciation potential based on current fundamentals which only improves if earnings or revenue surprise.

“… as a top 10 holding: Apple 67 Pfizer 45 Bank of America 37 Google 37 Jpmorgan Chase 36 Microsoft 36 Mastercard 29 Directv 27 Wells Fargo 27 CVS CAREMARK 24 Market Folly ... …”

CVS Caremark Corporation Talked About Near M&A Discussion on Fox Business

News broke today regarding mergers and acquisitions and CVS Caremark Corporation was discussed as well on Fox Business. Other sources will be required to know exactly what the context was in the discussion.

Based on our methodology, CVS Caremark Corporation should hold some appeal to value investors as we view it as Undervalued. Crowd sentiment is leaning to the bearish side, according to the robust data set collected by the Motley Fool CAPS survey. We noticed recently that in comparison to all other stocks we analyze in the news; CVS has received less coverage from the financial media in business television and blogs.

“… Last but not least, rite aid and number three drugstore chain between walgreens and CVS CAREMARK. They had a drop, nothing is good for them. …”

News Breaking on CVS Caremark Corporation on Squawk Box

The latest news from Squawk Box on CVS is available through Ockham's news analytics platform RazorWire.

The Motley Fool CAPS data suggests that investors believe CVS Caremark Corporation will beat the market in the foreseeable future. We consider CVS as Undervalued at the current price of $34.74. According to our methodology, this stock has appreciation potential based on current fundamentals which only improves if earnings or revenue surprise. As we analyze the results from RazorWire, one thing we do is rank each stock in terms of amount of news coverage. Recently, CVS has been less covered in the news compared to the rest of our universe of stocks.

“… i'm not saying it's controversial, but does the pending legislation create an opportunity at CVS CAREMARK? > > we like health care ideas that are levered to just volume ... …”

Stocks in the News: CVS Caremark Corporation Among the Twenty Most Discussed Stocks

Something important is going on with CVS today, as it is getting a lot of attention on business television and influential blogs.

As we analyze the results from RazorWire, one thing we do is rank each stock in terms of amount of news coverage. Recently, CVS has been less covered in the news compared to the rest of our universe of stocks. Check the news on this stock because there is a catalyst that has allowed this stock to advance 6.16% today. The Motley Fool CAPS data suggests that investors believe CVS Caremark Corporation will beat the market in the foreseeable future. We consider CVS as Undervalued at the current price of $32.98. According to our methodology, this stock has appreciation potential based on current fundamentals which only improves if earnings or revenue surprise.

“… Take a look at CVS CAREMARK, home home depot gets an upgrade. Cit naming john thain as its new ceo. > > two years ago wall street pumped $90 million to the democrats. …”

CVS Back in the News on Fox Business

It's been at least a month since we noticed any major news coverage of CVS, so the story in Fox Business may get the ball rolling.

Based on our methodology, CVS Caremark Corporation should hold some appeal to value investors as we view it as Undervalued. The latest news on CVS has created quite a stir as the stock is trading $1.83 higher in today's session. We noticed recently that in comparison to all other stocks we analyze in the news; CVS has received less coverage from the financial media in business television and blogs. Crowd sentiment is leaning to the bearish side, according to the robust data set collected by the Motley Fool CAPS survey.

“… Also CVS CAREMARK, caremark, this is one of the biggest movers in the s&p 500, helping that index to outperform the broader market. …”

Squawk On The Street: Discussion of CVS's Earnings

The name of the game in business is profit, and we always pay attention for CVS news as it relates to earnings.

The latest news on CVS has created quite a stir as the stock is trading $2.28 higher in today's session. Crowd sentiment is leaning to the bearish side, according to the robust data set collected by the Motley Fool CAPS survey. Based on our methodology, CVS Caremark Corporation should hold some appeal to value investors as we view it as Undervalued. We noticed recently that in comparison to all other stocks we analyze in the news; CVS has received less coverage from the financial media in business television and blogs.

“… Elsewhere, mixed reports on the earnings front, CVS CAREMARK did well but less than expected growth in the pharmacy services business. …”

See More News on CVS from Squawk On The Street

The latest news from Squawk On The Street on CVS is available through Ockham's news analytics platform RazorWire.

As we analyze the results from RazorWire, one thing we do is rank each stock in terms of amount of news coverage. Recently, CVS has been less covered in the news compared to the rest of our universe of stocks. We consider CVS as Undervalued at the current price of $32.19. According to our methodology, this stock has appreciation potential based on current fundamentals which only improves if earnings or revenue surprise. The Motley Fool CAPS data suggests that investors believe CVS Caremark Corporation will beat the market in the foreseeable future.

“… Same thing for CVS CAREMARK as well as express grip. Cvs up about a buck today good for 3%. Express scripts 5%. Both go to buy at goldman sachs. …”

Interested in CVS? See What the Pundits Said on Imus In The Morning

Wrote recently formed is under investigation by the ftc them started in august. Various groups past the government to look into CVS CAREMARK that it bought the benefit service and there has been changes including higher prices and compromised quality of care purpose citigroup planning the ipo of the primerica life insurance unit is of shares earlier it tried

“… are purpose citigroup planning the ipo of the primerica life insurance unit is of shares earlier it tried …”

First CVS News on Happy Hour in More Than a Month

Earnings. In an earnings conference call, cisco ceo john chambers gave a hopeful but cautious assessment about on the flipside, CVS CAREMARK was the s&p's biggest decliner down 20% though it beat forecasts. The drugstore lost billions worth of contracts in the pharmacy benefit segment. The s&p retail index was up 1.1% after a mix of same store retail sales numbers came in highlighted by high-end department stores

“… n the pharmacy benefit segment. The s&p retail index was up 1.1% after a mix of same store retail sales numbers came in highlighted by high-end department stores …”

CVS's Back in the News After More than a Month on Fox Business

Commercial break. Sorry, folks. The intraday high was a gain of 191 points. Gotta tell you the biggest loser stock of the day, CVS CAREMARK. Down 20%. It's the chain. Reported a 39% profit -- an increase in profit but it took $2 billion worth of losses from its pharmacy benefit unit and as a result the ceo says cvs will not reach its goals for next down goes the stock 20%. We talked a lot about coal this

“… om its pharmacy benefit unit and as a result the ceo says cvs will not reach its goals for next down goes the stock 20%. We talked a lot about coal this …”